nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0388	0.0879	CbGbCtD
Dofetilide—CYP3A4—Trimethadione—epilepsy syndrome	0.036	0.0817	CbGbCtD
Dofetilide—CYP3A4—Felbamate—epilepsy syndrome	0.036	0.0817	CbGbCtD
Dofetilide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0339	0.0768	CbGbCtD
Dofetilide—CYP3A4—Clonazepam—epilepsy syndrome	0.0306	0.0694	CbGbCtD
Dofetilide—CYP3A4—Clobazam—epilepsy syndrome	0.0294	0.0666	CbGbCtD
Dofetilide—CYP3A4—Rufinamide—epilepsy syndrome	0.025	0.0566	CbGbCtD
Dofetilide—CYP3A4—Carbamazepine—epilepsy syndrome	0.0243	0.0552	CbGbCtD
Dofetilide—CYP3A4—Primidone—epilepsy syndrome	0.0227	0.0515	CbGbCtD
Dofetilide—CYP3A4—Phenytoin—epilepsy syndrome	0.0218	0.0495	CbGbCtD
Dofetilide—CYP3A4—Propofol—epilepsy syndrome	0.0204	0.0462	CbGbCtD
Dofetilide—CYP3A4—Phenobarbital—epilepsy syndrome	0.0195	0.0441	CbGbCtD
Dofetilide—CYP3A4—Acetazolamide—epilepsy syndrome	0.0195	0.0441	CbGbCtD
Dofetilide—CYP3A4—Midazolam—epilepsy syndrome	0.0192	0.0435	CbGbCtD
Dofetilide—CYP3A4—Diazepam—epilepsy syndrome	0.0184	0.0418	CbGbCtD
Dofetilide—CYP3A4—Zonisamide—epilepsy syndrome	0.018	0.0408	CbGbCtD
Dofetilide—CYP3A4—Valproic Acid—epilepsy syndrome	0.0145	0.033	CbGbCtD
Dofetilide—CYP3A4—Topiramate—epilepsy syndrome	0.0131	0.0297	CbGbCtD
Dofetilide—KCNJ12—telencephalon—epilepsy syndrome	0.00659	0.147	CbGeAlD
Dofetilide—KCNJ12—medulla oblongata—epilepsy syndrome	0.00518	0.116	CbGeAlD
Dofetilide—KCNJ12—midbrain—epilepsy syndrome	0.00473	0.106	CbGeAlD
Dofetilide—KCNJ12—head—epilepsy syndrome	0.0041	0.0917	CbGeAlD
Dofetilide—KCNJ12—nervous system—epilepsy syndrome	0.00389	0.0869	CbGeAlD
Dofetilide—KCNJ12—central nervous system—epilepsy syndrome	0.00375	0.0837	CbGeAlD
Dofetilide—KCNJ12—cerebellum—epilepsy syndrome	0.00366	0.0818	CbGeAlD
Dofetilide—Dronedarone—HCN1—epilepsy syndrome	0.00331	0.333	CrCbGaD
Dofetilide—KCNJ12—brain—epilepsy syndrome	0.00297	0.0664	CbGeAlD
Dofetilide—Dronedarone—CACNB4—epilepsy syndrome	0.00281	0.284	CrCbGaD
Dofetilide—KCNK2—brain—epilepsy syndrome	0.0017	0.038	CbGeAlD
Dofetilide—KCNH2—forebrain—epilepsy syndrome	0.00114	0.0255	CbGeAlD
Dofetilide—Dronedarone—CACNA1D—epilepsy syndrome	0.00112	0.113	CrCbGaD
Dofetilide—KCNH2—telencephalon—epilepsy syndrome	0.00105	0.0235	CbGeAlD
Dofetilide—Dronedarone—SCN1A—epilepsy syndrome	0.000944	0.0951	CrCbGaD
Dofetilide—KCNH2—medulla oblongata—epilepsy syndrome	0.000825	0.0184	CbGeAlD
Dofetilide—KCNH2—midbrain—epilepsy syndrome	0.000754	0.0169	CbGeAlD
Dofetilide—KCNH2—spinal cord—epilepsy syndrome	0.000736	0.0164	CbGeAlD
Dofetilide—KCNH2—head—epilepsy syndrome	0.000654	0.0146	CbGeAlD
Dofetilide—KCNH2—nervous system—epilepsy syndrome	0.00062	0.0139	CbGeAlD
Dofetilide—KCNH2—central nervous system—epilepsy syndrome	0.000597	0.0133	CbGeAlD
Dofetilide—KCNH2—cerebellum—epilepsy syndrome	0.000584	0.013	CbGeAlD
Dofetilide—KCNH2—brain—epilepsy syndrome	0.000474	0.0106	CbGeAlD
Dofetilide—KCNJ12—Neuronal System—GRIK2—epilepsy syndrome	0.000412	0.00169	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—SLC1A3—epilepsy syndrome	0.000412	0.00169	CbGpPWpGaD
Dofetilide—Dronedarone—ADRA2A—epilepsy syndrome	0.00041	0.0413	CrCbGaD
Dofetilide—KCNJ12—Neuronal System—GAD1—epilepsy syndrome	0.000395	0.00162	CbGpPWpGaD
Dofetilide—CYP3A4—nervous system—epilepsy syndrome	0.000384	0.00859	CbGeAlD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000383	0.00157	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—NSF—epilepsy syndrome	0.000382	0.00157	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—SYN1—epilepsy syndrome	0.000382	0.00157	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—GABBR1—epilepsy syndrome	0.000377	0.00155	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—STXBP1—epilepsy syndrome	0.000371	0.00153	CbGpPWpGaD
Dofetilide—CYP3A4—central nervous system—epilepsy syndrome	0.00037	0.00827	CbGeAlD
Dofetilide—KCNJ12—Neuronal System—GRIA1—epilepsy syndrome	0.000367	0.00151	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—SLC6A1—epilepsy syndrome	0.000367	0.00151	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—GRIN2A—epilepsy syndrome	0.000367	0.00151	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—EPO—epilepsy syndrome	0.000367	0.00151	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000363	0.00149	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—SLC1A1—epilepsy syndrome	0.000362	0.00149	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000355	0.00146	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—CHRNB2—epilepsy syndrome	0.000348	0.00143	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.000347	0.00142	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—KCNJ10—epilepsy syndrome	0.000345	0.00142	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GABRA5—epilepsy syndrome	0.000345	0.00142	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GRIA4—epilepsy syndrome	0.000345	0.00142	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—CACNA1A—epilepsy syndrome	0.000345	0.00142	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—ABAT—epilepsy syndrome	0.000345	0.00142	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.000343	0.00141	CbGpPWpGaD
Dofetilide—Rosiglitazone—CYP2C19—epilepsy syndrome	0.000341	0.0344	CrCbGaD
Dofetilide—KCNH2—Potassium Channels—KCNJ10—epilepsy syndrome	0.000335	0.00138	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—ARHGEF9—epilepsy syndrome	0.000331	0.00136	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—SLC17A7—epilepsy syndrome	0.000331	0.00136	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GABRB3—epilepsy syndrome	0.000331	0.00136	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GABRA1—epilepsy syndrome	0.000331	0.00136	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GLUL—epilepsy syndrome	0.000325	0.00133	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.000322	0.00132	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.000322	0.00132	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GRIA2—epilepsy syndrome	0.000319	0.00131	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—CHRNA4—epilepsy syndrome	0.000316	0.0013	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—SLC1A2—epilepsy syndrome	0.000308	0.00126	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GRIK1—epilepsy syndrome	0.000308	0.00126	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—CHRNA7—epilepsy syndrome	0.000308	0.00126	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNC4—epilepsy syndrome	0.000299	0.00123	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNQ4—epilepsy syndrome	0.000299	0.00123	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNC1—epilepsy syndrome	0.000299	0.00123	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GABRB2—epilepsy syndrome	0.000294	0.00121	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GAD2—epilepsy syndrome	0.000289	0.00119	CbGpPWpGaD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000284	0.00117	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—BCHE—epilepsy syndrome	0.000278	0.00114	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—KCNMA1—epilepsy syndrome	0.000274	0.00113	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	0.000274	0.00113	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—DLG4—epilepsy syndrome	0.000272	0.00112	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNAB2—epilepsy syndrome	0.000267	0.0011	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCND2—epilepsy syndrome	0.000267	0.0011	CbGpPWpGaD
Dofetilide—KCNH2—Potassium Channels—KCNMA1—epilepsy syndrome	0.000266	0.00109	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—GRIN2B—epilepsy syndrome	0.000266	0.00109	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—PLCB1—epilepsy syndrome	0.000263	0.00108	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—SLC1A3—epilepsy syndrome	0.000262	0.00107	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—KCNJ11—epilepsy syndrome	0.000262	0.00107	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GRIK2—epilepsy syndrome	0.000262	0.00107	CbGpPWpGaD
Dofetilide—KCNH2—Potassium Channels—KCNJ11—epilepsy syndrome	0.000254	0.00104	CbGpPWpGaD
Dofetilide—Rosiglitazone—CYP2D6—epilepsy syndrome	0.000253	0.0255	CrCbGaD
Dofetilide—Oedema peripheral—Pregabalin—epilepsy syndrome	0.000253	0.000969	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000252	0.000967	CcSEcCtD
Dofetilide—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000252	0.000966	CcSEcCtD
Dofetilide—Sweating—Gabapentin—epilepsy syndrome	0.000251	0.000963	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—GAD1—epilepsy syndrome	0.000251	0.00103	CbGpPWpGaD
Dofetilide—Pain—Felbamate—epilepsy syndrome	0.000251	0.000962	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.00025	0.00103	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.00025	0.000961	CcSEcCtD
Dofetilide—Nausea—Lacosamide—epilepsy syndrome	0.00025	0.00096	CcSEcCtD
Dofetilide—Insomnia—Clonazepam—epilepsy syndrome	0.00025	0.00096	CcSEcCtD
Dofetilide—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000249	0.000957	CcSEcCtD
Dofetilide—Shock—Lamotrigine—epilepsy syndrome	0.000249	0.000957	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000249	0.000955	CcSEcCtD
Dofetilide—Insomnia—Phenytoin—epilepsy syndrome	0.000249	0.000954	CcSEcCtD
Dofetilide—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000248	0.000951	CcSEcCtD
Dofetilide—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000247	0.000949	CcSEcCtD
Dofetilide—Paraesthesia—Phenytoin—epilepsy syndrome	0.000247	0.000947	CcSEcCtD
Dofetilide—Dyspnoea—Clonazepam—epilepsy syndrome	0.000247	0.000946	CcSEcCtD
Dofetilide—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000245	0.00094	CcSEcCtD
Dofetilide—Dyspnoea—Phenytoin—epilepsy syndrome	0.000245	0.00094	CcSEcCtD
Dofetilide—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.000244	0.001	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNK9—epilepsy syndrome	0.000244	0.001	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNK3—epilepsy syndrome	0.000244	0.001	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GRIK5—epilepsy syndrome	0.000244	0.001	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CACNG3—epilepsy syndrome	0.000244	0.001	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.000244	0.001	CbGpPWpGaD
Dofetilide—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000244	0.000935	CcSEcCtD
Dofetilide—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000243	0.000933	CcSEcCtD
Dofetilide—Nausea—Clobazam—epilepsy syndrome	0.000243	0.000932	CcSEcCtD
Dofetilide—Asthenia—Propofol—epilepsy syndrome	0.000243	0.000932	CcSEcCtD
Dofetilide—Dizziness—Acetazolamide—epilepsy syndrome	0.000241	0.000925	CcSEcCtD
Dofetilide—Angina pectoris—Topiramate—epilepsy syndrome	0.000241	0.000923	CcSEcCtD
Dofetilide—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.00024	0.00092	CcSEcCtD
Dofetilide—Abdominal pain—Diazepam—epilepsy syndrome	0.00024	0.000919	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—GABBR1—epilepsy syndrome	0.000239	0.000983	CbGpPWpGaD
Dofetilide—Bradycardia—Gabapentin—epilepsy syndrome	0.000239	0.000918	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000239	0.000917	CcSEcCtD
Dofetilide—Back pain—Valproic Acid—epilepsy syndrome	0.000239	0.000916	CcSEcCtD
Dofetilide—Asthenia—Midazolam—epilepsy syndrome	0.000238	0.000912	CcSEcCtD
Dofetilide—Insomnia—Carbamazepine—epilepsy syndrome	0.000237	0.00091	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	0.000237	0.000974	CbGpPWpGaD
Dofetilide—Pain—Clonazepam—epilepsy syndrome	0.000237	0.000908	CcSEcCtD
Dofetilide—Paraesthesia—Carbamazepine—epilepsy syndrome	0.000236	0.000904	CcSEcCtD
Dofetilide—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000235	0.000901	CcSEcCtD
Dofetilide—Asthenia—Levetiracetam—epilepsy syndrome	0.000235	0.000901	CcSEcCtD
Dofetilide—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000234	0.000897	CcSEcCtD
Dofetilide—Pain—Oxcarbazepine—epilepsy syndrome	0.000234	0.000897	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—GRIN2A—epilepsy syndrome	0.000233	0.000958	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—SLC6A1—epilepsy syndrome	0.000233	0.000958	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GRIA1—epilepsy syndrome	0.000233	0.000958	CbGpPWpGaD
Dofetilide—KCNH2—Potassium Channels—GABBR1—epilepsy syndrome	0.000232	0.000954	CbGpPWpGaD
Dofetilide—Abdominal pain—Felbamate—epilepsy syndrome	0.000232	0.000889	CcSEcCtD
Dofetilide—Diarrhoea—Propofol—epilepsy syndrome	0.000232	0.000889	CcSEcCtD
Dofetilide—Oedema peripheral—Gabapentin—epilepsy syndrome	0.000232	0.000888	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000231	0.000886	CcSEcCtD
Dofetilide—Insomnia—Lamotrigine—epilepsy syndrome	0.000229	0.00088	CcSEcCtD
Dofetilide—Arrhythmia—Pregabalin—epilepsy syndrome	0.000229	0.000879	CcSEcCtD
Dofetilide—Headache—Acetazolamide—epilepsy syndrome	0.000228	0.000876	CcSEcCtD
Dofetilide—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000228	0.000873	CcSEcCtD
Dofetilide—Abdominal pain—Zonisamide—epilepsy syndrome	0.000227	0.000871	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—HCN1—epilepsy syndrome	0.000227	0.000932	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CACNG2—epilepsy syndrome	0.000227	0.000932	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNV1—epilepsy syndrome	0.000227	0.000932	CbGpPWpGaD
Dofetilide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000227	0.000869	CcSEcCtD
Dofetilide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000226	0.000868	CcSEcCtD
Dofetilide—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000226	0.000867	CcSEcCtD
Dofetilide—Angioedema—Valproic Acid—epilepsy syndrome	0.000226	0.000865	CcSEcCtD
Dofetilide—Pain—Carbamazepine—epilepsy syndrome	0.000224	0.000861	CcSEcCtD
Dofetilide—Dizziness—Propofol—epilepsy syndrome	0.000224	0.000859	CcSEcCtD
Dofetilide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000224	0.000859	CcSEcCtD
Dofetilide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000224	0.000858	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.000223	0.000917	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.000223	0.000917	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—CHRNB2—epilepsy syndrome	0.000221	0.000907	CbGpPWpGaD
Dofetilide—Asthenia—Vigabatrin—epilepsy syndrome	0.000221	0.000847	CcSEcCtD
Dofetilide—Dronedarone—CYP2D6—epilepsy syndrome	0.00022	0.0222	CrCbGaD
Dofetilide—Dizziness—Midazolam—epilepsy syndrome	0.000219	0.00084	CcSEcCtD
Dofetilide—Abdominal pain—Clonazepam—epilepsy syndrome	0.000219	0.000839	CcSEcCtD
Dofetilide—Palpitations—Valproic Acid—epilepsy syndrome	0.000218	0.000837	CcSEcCtD
Dofetilide—Asthenia—Diazepam—epilepsy syndrome	0.000217	0.000834	CcSEcCtD
Dofetilide—Pain—Lamotrigine—epilepsy syndrome	0.000217	0.000832	CcSEcCtD
Dofetilide—Nausea—Acetazolamide—epilepsy syndrome	0.000217	0.000831	CcSEcCtD
Dofetilide—Dizziness—Levetiracetam—epilepsy syndrome	0.000216	0.00083	CcSEcCtD
Dofetilide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000216	0.000829	CcSEcCtD
Dofetilide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000216	0.000829	CcSEcCtD
Dofetilide—Back pain—Pregabalin—epilepsy syndrome	0.000216	0.000828	CcSEcCtD
Dofetilide—Cough—Valproic Acid—epilepsy syndrome	0.000215	0.000826	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.000215	0.000882	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000215	0.000823	CcSEcCtD
Dofetilide—Urinary tract infection—Topiramate—epilepsy syndrome	0.000214	0.000822	CcSEcCtD
Dofetilide—Rash—Propofol—epilepsy syndrome	0.000214	0.000819	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—KCNQ3—epilepsy syndrome	0.000213	0.000876	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNQ2—epilepsy syndrome	0.000213	0.000876	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CHRNA2—epilepsy syndrome	0.000213	0.000876	CbGpPWpGaD
Dofetilide—Dermatitis—Propofol—epilepsy syndrome	0.000213	0.000818	CcSEcCtD
Dofetilide—Hypertension—Valproic Acid—epilepsy syndrome	0.000213	0.000818	CcSEcCtD
Dofetilide—Headache—Propofol—epilepsy syndrome	0.000212	0.000814	CcSEcCtD
Dofetilide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000211	0.000808	CcSEcCtD
Dofetilide—Asthenia—Felbamate—epilepsy syndrome	0.00021	0.000807	CcSEcCtD
Dofetilide—Arthralgia—Valproic Acid—epilepsy syndrome	0.00021	0.000806	CcSEcCtD
Dofetilide—Chest pain—Valproic Acid—epilepsy syndrome	0.00021	0.000806	CcSEcCtD
Dofetilide—Anxiety—Valproic Acid—epilepsy syndrome	0.000209	0.000803	CcSEcCtD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000209	0.00086	CbGpPWpGaD
Dofetilide—Rash—Midazolam—epilepsy syndrome	0.000209	0.000801	CcSEcCtD
Dofetilide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000209	0.000801	CcSEcCtD
Dofetilide—Dermatitis—Midazolam—epilepsy syndrome	0.000209	0.000801	CcSEcCtD
Dofetilide—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000208	0.000854	CbGpPWpGaD
Dofetilide—Headache—Midazolam—epilepsy syndrome	0.000208	0.000796	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.000208	0.000852	CbGpPWpGaD
Dofetilide—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000207	0.000796	CcSEcCtD
Dofetilide—Diarrhoea—Diazepam—epilepsy syndrome	0.000207	0.000795	CcSEcCtD
Dofetilide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000207	0.000795	CcSEcCtD
Dofetilide—Rash—Levetiracetam—epilepsy syndrome	0.000206	0.000791	CcSEcCtD
Dofetilide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000206	0.000791	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	0.000206	0.000847	CbGpPWpGaD
Dofetilide—Asthenia—Zonisamide—epilepsy syndrome	0.000206	0.00079	CcSEcCtD
Dofetilide—Headache—Levetiracetam—epilepsy syndrome	0.000205	0.000786	CcSEcCtD
Dofetilide—Angioedema—Pregabalin—epilepsy syndrome	0.000204	0.000782	CcSEcCtD
Dofetilide—Dizziness—Vigabatrin—epilepsy syndrome	0.000204	0.000781	CcSEcCtD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.000203	0.000834	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CACNB4—epilepsy syndrome	0.000202	0.000831	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CACNA2D2—epilepsy syndrome	0.000202	0.000831	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNB1—epilepsy syndrome	0.000202	0.000831	CbGpPWpGaD
Dofetilide—Oedema—Valproic Acid—epilepsy syndrome	0.000201	0.000773	CcSEcCtD
Dofetilide—Bradycardia—Topiramate—epilepsy syndrome	0.000201	0.000772	CcSEcCtD
Dofetilide—Nausea—Propofol—epilepsy syndrome	0.000201	0.000772	CcSEcCtD
Dofetilide—Diarrhoea—Felbamate—epilepsy syndrome	0.000201	0.00077	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—CHRNA4—epilepsy syndrome	0.000201	0.000824	CbGpPWpGaD
Dofetilide—Abdominal pain—Lamotrigine—epilepsy syndrome	0.0002	0.000769	CcSEcCtD
Dofetilide—Dizziness—Diazepam—epilepsy syndrome	0.0002	0.000769	CcSEcCtD
Dofetilide—Syncope—Pregabalin—epilepsy syndrome	0.0002	0.000768	CcSEcCtD
Dofetilide—Rash—Fosphenytoin—epilepsy syndrome	0.000199	0.000764	CcSEcCtD
Dofetilide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000199	0.000763	CcSEcCtD
Dofetilide—Asthenia—Clonazepam—epilepsy syndrome	0.000199	0.000762	CcSEcCtD
Dofetilide—Back pain—Gabapentin—epilepsy syndrome	0.000198	0.000759	CcSEcCtD
Dofetilide—Headache—Fosphenytoin—epilepsy syndrome	0.000198	0.000759	CcSEcCtD
Dofetilide—Palpitations—Pregabalin—epilepsy syndrome	0.000197	0.000757	CcSEcCtD
Dofetilide—Asthenia—Phenytoin—epilepsy syndrome	0.000197	0.000756	CcSEcCtD
Dofetilide—Nausea—Midazolam—epilepsy syndrome	0.000197	0.000755	CcSEcCtD
Dofetilide—Diarrhoea—Zonisamide—epilepsy syndrome	0.000196	0.000754	CcSEcCtD
Dofetilide—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000196	0.000752	CcSEcCtD
Dofetilide—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000196	0.000752	CcSEcCtD
Dofetilide—Oedema peripheral—Topiramate—epilepsy syndrome	0.000195	0.000747	CcSEcCtD
Dofetilide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000195	0.000747	CcSEcCtD
Dofetilide—Cough—Pregabalin—epilepsy syndrome	0.000195	0.000747	CcSEcCtD
Dofetilide—Nausea—Levetiracetam—epilepsy syndrome	0.000194	0.000746	CcSEcCtD
Dofetilide—Rash—Vigabatrin—epilepsy syndrome	0.000194	0.000745	CcSEcCtD
Dofetilide—Dizziness—Felbamate—epilepsy syndrome	0.000194	0.000744	CcSEcCtD
Dofetilide—Dermatitis—Vigabatrin—epilepsy syndrome	0.000194	0.000744	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GABRG2—epilepsy syndrome	0.000193	0.000792	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNH1—epilepsy syndrome	0.000193	0.000792	CbGpPWpGaD
Dofetilide—Headache—Vigabatrin—epilepsy syndrome	0.000193	0.00074	CcSEcCtD
Dofetilide—Hypertension—Pregabalin—epilepsy syndrome	0.000193	0.000739	CcSEcCtD
Dofetilide—Rash—Diazepam—epilepsy syndrome	0.000191	0.000733	CcSEcCtD
Dofetilide—Dermatitis—Diazepam—epilepsy syndrome	0.000191	0.000732	CcSEcCtD
Dofetilide—Chest pain—Pregabalin—epilepsy syndrome	0.00019	0.000729	CcSEcCtD
Dofetilide—Arthralgia—Pregabalin—epilepsy syndrome	0.00019	0.000729	CcSEcCtD
Dofetilide—Dizziness—Zonisamide—epilepsy syndrome	0.00019	0.000728	CcSEcCtD
Dofetilide—Headache—Diazepam—epilepsy syndrome	0.00019	0.000728	CcSEcCtD
Dofetilide—Anxiety—Pregabalin—epilepsy syndrome	0.000189	0.000726	CcSEcCtD
Dofetilide—Diarrhoea—Clonazepam—epilepsy syndrome	0.000189	0.000726	CcSEcCtD
Dofetilide—Rosiglitazone—ALB—epilepsy syndrome	0.000189	0.0191	CrCbGaD
Dofetilide—Asthenia—Carbamazepine—epilepsy syndrome	0.000188	0.000722	CcSEcCtD
Dofetilide—Diarrhoea—Phenytoin—epilepsy syndrome	0.000188	0.000721	CcSEcCtD
Dofetilide—Nausea—Fosphenytoin—epilepsy syndrome	0.000188	0.00072	CcSEcCtD
Dofetilide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000187	0.000718	CcSEcCtD
Dofetilide—Angioedema—Gabapentin—epilepsy syndrome	0.000187	0.000717	CcSEcCtD
Dofetilide—Rash—Felbamate—epilepsy syndrome	0.000185	0.000709	CcSEcCtD
Dofetilide—Dermatitis—Felbamate—epilepsy syndrome	0.000185	0.000709	CcSEcCtD
Dofetilide—Headache—Felbamate—epilepsy syndrome	0.000184	0.000705	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000184	0.000704	CcSEcCtD
Dofetilide—Syncope—Gabapentin—epilepsy syndrome	0.000184	0.000704	CcSEcCtD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—FOS—epilepsy syndrome	0.000183	0.000753	CbGpPWpGaD
Dofetilide—Dizziness—Clonazepam—epilepsy syndrome	0.000183	0.000702	CcSEcCtD
Dofetilide—Nausea—Vigabatrin—epilepsy syndrome	0.000183	0.000701	CcSEcCtD
Dofetilide—Insomnia—Valproic Acid—epilepsy syndrome	0.000182	0.000699	CcSEcCtD
Dofetilide—Oedema—Pregabalin—epilepsy syndrome	0.000182	0.000699	CcSEcCtD
Dofetilide—Asthenia—Lamotrigine—epilepsy syndrome	0.000182	0.000698	CcSEcCtD
Dofetilide—Dizziness—Phenytoin—epilepsy syndrome	0.000182	0.000697	CcSEcCtD
Dofetilide—Rash—Zonisamide—epilepsy syndrome	0.000181	0.000694	CcSEcCtD
Dofetilide—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000181	0.000694	CcSEcCtD
Dofetilide—Palpitations—Gabapentin—epilepsy syndrome	0.000181	0.000694	CcSEcCtD
Dofetilide—Dermatitis—Zonisamide—epilepsy syndrome	0.000181	0.000694	CcSEcCtD
Dofetilide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000181	0.000694	CcSEcCtD
Dofetilide—Nausea—Diazepam—epilepsy syndrome	0.00018	0.000691	CcSEcCtD
Dofetilide—Loss of consciousness—Gabapentin—epilepsy syndrome	0.00018	0.00069	CcSEcCtD
Dofetilide—Headache—Zonisamide—epilepsy syndrome	0.00018	0.00069	CcSEcCtD
Dofetilide—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00018	0.000689	CcSEcCtD
Dofetilide—Diarrhoea—Carbamazepine—epilepsy syndrome	0.00018	0.000689	CcSEcCtD
Dofetilide—Shock—Pregabalin—epilepsy syndrome	0.000179	0.000687	CcSEcCtD
Dofetilide—Cough—Gabapentin—epilepsy syndrome	0.000179	0.000685	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—BCHE—epilepsy syndrome	0.000177	0.000726	CbGpPWpGaD
Dofetilide—Hypertension—Gabapentin—epilepsy syndrome	0.000177	0.000678	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.000176	0.000725	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.000176	0.000725	CbGpPWpGaD
Dofetilide—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000176	0.000675	CcSEcCtD
Dofetilide—Rash—Clonazepam—epilepsy syndrome	0.000174	0.000669	CcSEcCtD
Dofetilide—Dermatitis—Clonazepam—epilepsy syndrome	0.000174	0.000669	CcSEcCtD
Dofetilide—Arthralgia—Gabapentin—epilepsy syndrome	0.000174	0.000668	CcSEcCtD
Dofetilide—Chest pain—Gabapentin—epilepsy syndrome	0.000174	0.000668	CcSEcCtD
Dofetilide—Nausea—Felbamate—epilepsy syndrome	0.000174	0.000668	CcSEcCtD
Dofetilide—Anxiety—Gabapentin—epilepsy syndrome	0.000174	0.000666	CcSEcCtD
Dofetilide—Dizziness—Carbamazepine—epilepsy syndrome	0.000173	0.000665	CcSEcCtD
Dofetilide—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000173	0.000665	CcSEcCtD
Dofetilide—Headache—Clonazepam—epilepsy syndrome	0.000173	0.000665	CcSEcCtD
Dofetilide—Rash—Phenytoin—epilepsy syndrome	0.000173	0.000665	CcSEcCtD
Dofetilide—Dermatitis—Phenytoin—epilepsy syndrome	0.000173	0.000664	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—DLG4—epilepsy syndrome	0.000173	0.000709	CbGpPWpGaD
Dofetilide—Rash—Oxcarbazepine—epilepsy syndrome	0.000172	0.000661	CcSEcCtD
Dofetilide—Pain—Valproic Acid—epilepsy syndrome	0.000172	0.000661	CcSEcCtD
Dofetilide—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	0.000172	0.000707	CbGpPWpGaD
Dofetilide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000172	0.000661	CcSEcCtD
Dofetilide—Headache—Phenytoin—epilepsy syndrome	0.000172	0.00066	CcSEcCtD
Dofetilide—Headache—Oxcarbazepine—epilepsy syndrome	0.000171	0.000657	CcSEcCtD
Dofetilide—Nausea—Zonisamide—epilepsy syndrome	0.000171	0.000654	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—GRIN2B—epilepsy syndrome	0.000169	0.000693	CbGpPWpGaD
Dofetilide—Dizziness—Lamotrigine—epilepsy syndrome	0.000168	0.000643	CcSEcCtD
Dofetilide—Oedema—Gabapentin—epilepsy syndrome	0.000167	0.000641	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—PLCB1—epilepsy syndrome	0.000167	0.000685	CbGpPWpGaD
Dofetilide—Back pain—Topiramate—epilepsy syndrome	0.000167	0.000639	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000166	0.000637	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.000166	0.000681	CbGpPWpGaD
Dofetilide—Rash—Carbamazepine—epilepsy syndrome	0.000165	0.000635	CcSEcCtD
Dofetilide—Dermatitis—Carbamazepine—epilepsy syndrome	0.000165	0.000634	CcSEcCtD
Dofetilide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000165	0.000632	CcSEcCtD
Dofetilide—Insomnia—Pregabalin—epilepsy syndrome	0.000165	0.000632	CcSEcCtD
Dofetilide—Dronedarone—ALB—epilepsy syndrome	0.000164	0.0166	CrCbGaD
Dofetilide—Nausea—Clonazepam—epilepsy syndrome	0.000164	0.00063	CcSEcCtD
Dofetilide—Headache—Carbamazepine—epilepsy syndrome	0.000164	0.00063	CcSEcCtD
Dofetilide—Shock—Gabapentin—epilepsy syndrome	0.000164	0.00063	CcSEcCtD
Dofetilide—Paraesthesia—Pregabalin—epilepsy syndrome	0.000164	0.000627	CcSEcCtD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.000163	0.000671	CbGpPWpGaD
Dofetilide—Nausea—Phenytoin—epilepsy syndrome	0.000163	0.000626	CcSEcCtD
Dofetilide—Dyspnoea—Pregabalin—epilepsy syndrome	0.000162	0.000623	CcSEcCtD
Dofetilide—Nausea—Oxcarbazepine—epilepsy syndrome	0.000162	0.000623	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—SYN1—epilepsy syndrome	0.000162	0.000664	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—NSF—epilepsy syndrome	0.000162	0.000664	CbGpPWpGaD
Dofetilide—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000161	0.000619	CcSEcCtD
Dofetilide—Rash—Lamotrigine—epilepsy syndrome	0.00016	0.000613	CcSEcCtD
Dofetilide—Dermatitis—Lamotrigine—epilepsy syndrome	0.00016	0.000613	CcSEcCtD
Dofetilide—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000159	0.000611	CcSEcCtD
Dofetilide—Headache—Lamotrigine—epilepsy syndrome	0.000159	0.000609	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—PRKCB—epilepsy syndrome	0.000158	0.000649	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—STXBP1—epilepsy syndrome	0.000157	0.000646	CbGpPWpGaD
Dofetilide—Dronedarone—ABCB1—epilepsy syndrome	0.000157	0.0158	CrCbGaD
Dofetilide—Nausea—Carbamazepine—epilepsy syndrome	0.000156	0.000598	CcSEcCtD
Dofetilide—Pain—Pregabalin—epilepsy syndrome	0.000156	0.000598	CcSEcCtD
Dofetilide—Syncope—Topiramate—epilepsy syndrome	0.000154	0.000592	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—SLC1A1—epilepsy syndrome	0.000153	0.00063	CbGpPWpGaD
Dofetilide—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	0.000152	0.000625	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000152	0.000584	CcSEcCtD
Dofetilide—Palpitations—Topiramate—epilepsy syndrome	0.000152	0.000584	CcSEcCtD
Dofetilide—Loss of consciousness—Topiramate—epilepsy syndrome	0.000151	0.000581	CcSEcCtD
Dofetilide—Insomnia—Gabapentin—epilepsy syndrome	0.000151	0.00058	CcSEcCtD
Dofetilide—Nausea—Lamotrigine—epilepsy syndrome	0.000151	0.000578	CcSEcCtD
Dofetilide—Cough—Topiramate—epilepsy syndrome	0.00015	0.000576	CcSEcCtD
Dofetilide—Paraesthesia—Gabapentin—epilepsy syndrome	0.00015	0.000575	CcSEcCtD
Dofetilide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000149	0.000571	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.000149	0.000612	CbGpPWpGaD
Dofetilide—Dyspnoea—Gabapentin—epilepsy syndrome	0.000149	0.000571	CcSEcCtD
Dofetilide—Hypertension—Topiramate—epilepsy syndrome	0.000149	0.00057	CcSEcCtD
Dofetilide—Chest pain—Topiramate—epilepsy syndrome	0.000147	0.000562	CcSEcCtD
Dofetilide—Arthralgia—Topiramate—epilepsy syndrome	0.000147	0.000562	CcSEcCtD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.000146	0.000601	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNJ10—epilepsy syndrome	0.000146	0.000601	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GRIA4—epilepsy syndrome	0.000146	0.000601	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CACNA1A—epilepsy syndrome	0.000146	0.000601	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GABRA5—epilepsy syndrome	0.000146	0.000601	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—ABAT—epilepsy syndrome	0.000146	0.000601	CbGpPWpGaD
Dofetilide—Anxiety—Topiramate—epilepsy syndrome	0.000146	0.00056	CcSEcCtD
Dofetilide—Asthenia—Valproic Acid—epilepsy syndrome	0.000145	0.000555	CcSEcCtD
Dofetilide—Abdominal pain—Pregabalin—epilepsy syndrome	0.000144	0.000552	CcSEcCtD
Dofetilide—Pain—Gabapentin—epilepsy syndrome	0.000143	0.000548	CcSEcCtD
Dofetilide—Oedema—Topiramate—epilepsy syndrome	0.000141	0.000539	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GABRB3—epilepsy syndrome	0.00014	0.000576	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—ARHGEF9—epilepsy syndrome	0.00014	0.000576	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—SLC17A7—epilepsy syndrome	0.00014	0.000576	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GABRA1—epilepsy syndrome	0.00014	0.000576	CbGpPWpGaD
Dofetilide—Shock—Topiramate—epilepsy syndrome	0.000138	0.00053	CcSEcCtD
Dofetilide—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000138	0.000529	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GLUL—epilepsy syndrome	0.000137	0.000565	CbGpPWpGaD
Dofetilide—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	0.000137	0.000561	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000137	0.000524	CcSEcCtD
Dofetilide—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000136	0.000521	CcSEcCtD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—epilepsy syndrome	0.000136	0.000558	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.000135	0.000555	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GRIA2—epilepsy syndrome	0.000135	0.000554	CbGpPWpGaD
Dofetilide—Dizziness—Valproic Acid—epilepsy syndrome	0.000133	0.000511	CcSEcCtD
Dofetilide—Abdominal pain—Gabapentin—epilepsy syndrome	0.000132	0.000506	CcSEcCtD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	0.000131	0.000539	CbGpPWpGaD
Dofetilide—Asthenia—Pregabalin—epilepsy syndrome	0.000131	0.000501	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—SLC1A2—epilepsy syndrome	0.00013	0.000535	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GRIK1—epilepsy syndrome	0.00013	0.000535	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CHRNA7—epilepsy syndrome	0.00013	0.000535	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000128	0.000491	CcSEcCtD
Dofetilide—Insomnia—Topiramate—epilepsy syndrome	0.000127	0.000488	CcSEcCtD
Dofetilide—Rash—Valproic Acid—epilepsy syndrome	0.000127	0.000487	CcSEcCtD
Dofetilide—Dermatitis—Valproic Acid—epilepsy syndrome	0.000127	0.000487	CcSEcCtD
Dofetilide—Headache—Valproic Acid—epilepsy syndrome	0.000126	0.000484	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000126	0.000518	CbGpPWpGaD
Dofetilide—Paraesthesia—Topiramate—epilepsy syndrome	0.000126	0.000484	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.000126	0.000516	CbGpPWpGaD
Dofetilide—Dyspnoea—Topiramate—epilepsy syndrome	0.000125	0.000481	CcSEcCtD
Dofetilide—Diarrhoea—Pregabalin—epilepsy syndrome	0.000125	0.000478	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GABRB2—epilepsy syndrome	0.000124	0.000511	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GAD2—epilepsy syndrome	0.000123	0.000503	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000122	0.000502	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000122	0.000502	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000122	0.0005	CbGpPWpGaD
Dofetilide—Dizziness—Pregabalin—epilepsy syndrome	0.00012	0.000462	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.00012	0.000494	CbGpPWpGaD
Dofetilide—Pain—Topiramate—epilepsy syndrome	0.00012	0.000461	CcSEcCtD
Dofetilide—Asthenia—Gabapentin—epilepsy syndrome	0.00012	0.00046	CcSEcCtD
Dofetilide—Nausea—Valproic Acid—epilepsy syndrome	0.00012	0.000459	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—KCNMA1—epilepsy syndrome	0.000116	0.000477	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000115	0.000441	CcSEcCtD
Dofetilide—Rash—Pregabalin—epilepsy syndrome	0.000115	0.000441	CcSEcCtD
Dofetilide—Dermatitis—Pregabalin—epilepsy syndrome	0.000115	0.00044	CcSEcCtD
Dofetilide—Diarrhoea—Gabapentin—epilepsy syndrome	0.000114	0.000438	CcSEcCtD
Dofetilide—Headache—Pregabalin—epilepsy syndrome	0.000114	0.000438	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.000112	0.00046	CbGpPWpGaD
Dofetilide—Abdominal pain—Topiramate—epilepsy syndrome	0.000111	0.000426	CcSEcCtD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	0.000111	0.000456	CbGpPWpGaD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000111	0.000455	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—SLC1A3—epilepsy syndrome	0.000111	0.000455	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GRIK2—epilepsy syndrome	0.000111	0.000455	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNJ11—epilepsy syndrome	0.000111	0.000455	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.00011	0.000454	CbGpPWpGaD
Dofetilide—Dizziness—Gabapentin—epilepsy syndrome	0.00011	0.000424	CcSEcCtD
Dofetilide—Nausea—Pregabalin—epilepsy syndrome	0.000108	0.000415	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GAD1—epilepsy syndrome	0.000106	0.000436	CbGpPWpGaD
Dofetilide—Rash—Gabapentin—epilepsy syndrome	0.000105	0.000404	CcSEcCtD
Dofetilide—Dermatitis—Gabapentin—epilepsy syndrome	0.000105	0.000404	CcSEcCtD
Dofetilide—Headache—Gabapentin—epilepsy syndrome	0.000105	0.000401	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.000105	0.000429	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GABBR1—epilepsy syndrome	0.000101	0.000416	CbGpPWpGaD
Dofetilide—Asthenia—Topiramate—epilepsy syndrome	0.000101	0.000387	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—PRKCB—epilepsy syndrome	0.0001	0.000412	CbGpPWpGaD
Dofetilide—Nausea—Gabapentin—epilepsy syndrome	9.92e-05	0.000381	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GRIA1—epilepsy syndrome	9.88e-05	0.000406	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—SLC6A1—epilepsy syndrome	9.88e-05	0.000406	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GRIN2A—epilepsy syndrome	9.88e-05	0.000406	CbGpPWpGaD
Dofetilide—Diarrhoea—Topiramate—epilepsy syndrome	9.61e-05	0.000369	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—CHRNB2—epilepsy syndrome	9.35e-05	0.000384	CbGpPWpGaD
Dofetilide—Dizziness—Topiramate—epilepsy syndrome	9.29e-05	0.000356	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	9.27e-05	0.000381	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	9.13e-05	0.000375	CbGpPWpGaD
Dofetilide—Rash—Topiramate—epilepsy syndrome	8.86e-05	0.00034	CcSEcCtD
Dofetilide—Dermatitis—Topiramate—epilepsy syndrome	8.85e-05	0.00034	CcSEcCtD
Dofetilide—Headache—Topiramate—epilepsy syndrome	8.8e-05	0.000338	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	8.76e-05	0.00036	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—CHRNA4—epilepsy syndrome	8.49e-05	0.000349	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	8.48e-05	0.000348	CbGpPWpGaD
Dofetilide—Nausea—Topiramate—epilepsy syndrome	8.35e-05	0.00032	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	8.19e-05	0.000336	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	8.14e-05	0.000334	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	8.1e-05	0.000333	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	8.06e-05	0.000331	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	7.71e-05	0.000317	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—BCHE—epilepsy syndrome	7.49e-05	0.000307	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—DLG4—epilepsy syndrome	7.31e-05	0.0003	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GRIN2B—epilepsy syndrome	7.14e-05	0.000293	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—PLCB1—epilepsy syndrome	7.06e-05	0.00029	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	6.7e-05	0.000275	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	6.38e-05	0.000262	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	6.37e-05	0.000261	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	6.32e-05	0.00026	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	6.28e-05	0.000258	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	6.24e-05	0.000256	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	6.2e-05	0.000255	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	5.67e-05	0.000233	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	5.6e-05	0.00023	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	5.15e-05	0.000211	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	5.13e-05	0.000211	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	5.09e-05	0.000209	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	4.6e-05	0.000189	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	4.57e-05	0.000188	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	4.56e-05	0.000187	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	4.43e-05	0.000182	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—PRKCB—epilepsy syndrome	4.25e-05	0.000174	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	3.87e-05	0.000159	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	3.32e-05	0.000136	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.78e-05	0.000114	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.72e-05	0.000112	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2.71e-05	0.000111	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.69e-05	0.00011	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.67e-05	0.00011	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.44e-05	0.0001	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.41e-05	9.89e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.25e-05	9.25e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.86e-05	7.65e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.41e-05	5.8e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.41e-05	5.8e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.41e-05	5.8e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.41e-05	5.8e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.41e-05	5.8e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.41e-05	5.8e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.29e-05	5.3e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.29e-05	5.3e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.29e-05	5.3e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.29e-05	5.3e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.2e-05	4.93e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.2e-05	4.93e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.2e-05	4.91e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.13e-05	4.63e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.07e-05	4.39e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.07e-05	4.39e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.07e-05	4.39e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.07e-05	4.39e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.07e-05	4.39e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	9.78e-06	4.02e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	9.78e-06	4.02e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	9.78e-06	4.02e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.42e-06	3.87e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	9.1e-06	3.74e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	9.1e-06	3.74e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.55e-06	3.51e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	8.32e-06	3.42e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	8.11e-06	3.33e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	8.11e-06	3.33e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.73e-06	3.18e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.73e-06	3.18e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.57e-06	3.11e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.42e-06	3.05e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	7.27e-06	2.99e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	7.14e-06	2.93e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.68e-06	2.74e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.48e-06	2.66e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.86e-06	2.41e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.86e-06	2.41e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.78e-06	1.96e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.66e-06	1.91e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.63e-06	1.9e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.18e-06	1.72e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.98e-06	1.63e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.96e-06	1.63e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.78e-06	1.55e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.74e-06	1.53e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—TH—epilepsy syndrome	3.72e-06	1.53e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.11e-06	1.28e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.07e-06	1.26e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.98e-06	1.22e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.77e-06	1.14e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.43e-06	9.98e-06	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.38e-06	9.78e-06	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.05e-06	8.4e-06	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.87e-06	7.66e-06	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.63e-06	6.7e-06	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	8.2e-07	3.37e-06	CbGpPWpGaD
